Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction

Author:

Yan Jin1,Yao Yu2,Yan Siqi3,Gao Ruqing4,Lu Wuyuan5ORCID,He Wangxiao67ORCID

Affiliation:

1. National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China

2. Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

3. Ophthalmology Department, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

4. School of Medicine, Nanchang University, Nanchang 330006, China

5. Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States

6. Department of Talent Highland, The First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an 710061, China

7. The Second Affiliated Hospital of Xi’an Jiao Tong University, Xi’an 710061, China

Funder

Ministry of Education of the People's Republic of China

China Postdoctoral Science Foundation

Natural Science Foundation of Shaanxi Province

Thousand Talents Plan of Shaanxi Province

Xi'an Jiaotong University

Institutional Science Foundation of The First Affiliated Hospital of Xi'an Jiaotong University

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Cited by 185 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3